Atomoxetine in <font color="red">autism_2</font> <font color="red">spectrum_2</font> <font color="red">disorder_2</font> <font color="red">:_2</font> no effects on social functioning ; some beneficial effects on stereotyped behaviors , inappropriate speech , and fear of change . 
<br>
<br> UNLABELLED Abstract Objective : The objective of this study was to investigate the short - term treatment effects of atomoxetine on <font color="red">autism_2</font> <font color="red">spectrum_2</font> <font color="red">disorder_2</font> <font color="red">(_2</font> <font color="red">ASD_2</font> <font color="red">)_2</font> <font color="red">symptoms_2</font> <font color="red">in_2</font> <font color="red">children_2</font> <font color="red">and_2</font> <font color="red">adolescents_2</font> <font color="red">with_2</font> <font color="red">both_2</font> <font color="red">ASD_2</font> <font color="red">and_2</font> <font color="red">attention_2</font> <font color="red">-_2</font> <font color="red">deficit_2</font> <font color="red">/_2</font> <font color="red">hyperactivity_2</font> <font color="red">disorder_2</font> <font color="red">(_2</font> <font color="red">ADHD_2</font> <font color="red">)_2</font> <font color="red">._2</font> 
<br> METHODS A total of <font color="red">97_2</font> <font color="red">patients_2</font> <font color="red">6_2</font> <font color="red">-_2</font> <font color="red">17_2</font> <font color="red">years_2</font> <font color="red">of_2</font> <font color="red">age_2</font> <font color="red">,_2</font> <font color="red">with_2</font> <font color="red">ASD_2</font> <font color="red">and_2</font> <font color="red">ADHD_2</font> <font color="red">,_2</font> were treated with 1.2 â€‰ mg / kg / day of atomoxetine during an 8 week double - blind placebo - controlled period . Here , we investigated effects on two parent - based secondary outcome measures , the Aberrant Behavior Checklist ( ABC ) and the Children 's Social Behavior Questionnaire ( CSBQ ) . 
<br> RESULTS After 8 weeks of double - blind treatment , atomoxetine administration was associated with significant treatment effects on the ABC subscales Hyperactivity , Inappropriate Speech , and Stereotypic Behavior , and on the CSBQ subscale Fear for Changes . 
<br> CONCLUSIONS Our study results indicate no beneficial effects of atomoxetine on social functioning . However , atomoxetine may ameliorate restricted and stereotyped behaviors and communication . This study has been registered in ClinicalTrials.gov ( www.clinicaltrials.gov ) under registration number NCT00380692 .